<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id>
      <journal-id journal-id-type="iso-abbrev">Hum Mol Genet</journal-id>
      <journal-id journal-id-type="publisher-id">hmg</journal-id>
      <journal-title-group>
        <journal-title>Human Molecular Genetics</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0964-6906</issn>
      <issn pub-type="epub">1460-2083</issn>
      <publisher>
        <publisher-name>Oxford University Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">34999892</article-id>
      <article-id pub-id-type="pmc">9239743</article-id>
      <article-id pub-id-type="doi">10.1093/hmg/ddab368</article-id>
      <article-id pub-id-type="publisher-id">ddab368</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
        <subj-group subj-group-type="category-taxonomy-collection">
          <subject>AcademicSubjects/SCI01140</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Mutations in the ribosome biogenesis factor gene <italic toggle="yes">LTV1</italic> are linked to LIPHAK syndrome, a novel poikiloderma-like disorder</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Han</surname>
            <given-names>Ji Hoon</given-names>
          </name>
          <!--jihoon.han@iob.ch-->
          <aff>
<institution>Institute of Molecular and Clinical Ophthalmology Basel (IOB)</institution>, <addr-line>4031 Basel</addr-line>, <country country="CH">Switzerland</country></aff>
          <aff>
<institution>Department of Ophthalmology</institution>, University of Basel, <addr-line>4031 Basel</addr-line>, <country country="CH">Switzerland</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ryan</surname>
            <given-names>Gavin</given-names>
          </name>
          <!--gavin.ryan@nhs.net-->
          <aff>
<institution>West Midlands Regional Genetics Laboratory</institution>, Central and South Genomic Laboratory Hub, Birmingham <addr-line>B15 2TG</addr-line>, <country country="GB">UK</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Guy</surname>
            <given-names>Alyson</given-names>
          </name>
          <!--Alyson.Guy@gstt.nhs.uk-->
          <aff>
<institution>Viapath</institution>, St Thomas' Hospital, London <addr-line>SE1 7EH</addr-line>, <country country="GB">UK</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Lu</given-names>
          </name>
          <!--lu.liu@viapath.co.uk-->
          <aff>
<institution>Viapath</institution>, St Thomas' Hospital, London <addr-line>SE1 7EH</addr-line>, <country country="GB">UK</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Quinodoz</surname>
            <given-names>Mathieu</given-names>
          </name>
          <!--mathieu.quinodoz@iob.ch-->
          <aff>
<institution>Institute of Molecular and Clinical Ophthalmology Basel (IOB)</institution>, <addr-line>4031 Basel</addr-line>, <country country="CH">Switzerland</country></aff>
          <aff>
<institution>Department of Ophthalmology</institution>, University of Basel, <addr-line>4031 Basel</addr-line>, <country country="CH">Switzerland</country></aff>
          <aff>
<institution>Department of Genetics and Genome Biology</institution>, University of Leicester, <addr-line>Leicester LE1 7RH</addr-line>, <country country="GB">UK</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Helbling</surname>
            <given-names>Ingrid</given-names>
          </name>
          <!--ingrid.helbling@uhl-tr.nhs.uk-->
          <aff>
<institution>Department of Dermatology</institution>, University Hospitals of Leicester NHS Trust, <addr-line>Leicester LE1 5WW</addr-line>, <country country="GB">UK</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lai-Cheong</surname>
            <given-names>Joey E</given-names>
          </name>
          <!--joey.laicheong@gmail.com-->
          <aff>
<institution>Frimley Park NHS Foundation Trust</institution>, <addr-line>Camberley GU16 7UJ</addr-line>, <country country="GB">UK</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <collab>Genomics England Research Consortium</collab>
          <aff>
<institution>&#xA0;</institution>
<ext-link xlink:href="https://www.genomicsengland.co.uk/wp-content/uploads/2021/05/Genomics-England-Research-Consortium-author-full-names-list-3.pdf" ext-link-type="uri">https://www.genomicsengland.co.uk/wp-content/uploads/2021/05/Genomics-England-Research-Consortium-author-full-names-list-3.pdf</ext-link>
</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barwell</surname>
            <given-names>Julian</given-names>
          </name>
          <!--Julian.Barwell@uhl-tr.nhs.uk-->
          <aff>
<institution>Department of Genetics and Genome Biology</institution>, University of Leicester, <addr-line>Leicester LE1 7RH</addr-line>, <country country="GB">UK</country></aff>
          <aff>
<institution>Department of Clinical Genetics</institution>, University Hospitals of Leicester NHS Trust, <addr-line>Leicester LE1 5WW</addr-line>, <country country="GB">UK</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Folcher</surname>
            <given-names>Marc</given-names>
          </name>
          <!--marc.folcher@iob.ch-->
          <aff>
<institution>Institute of Molecular and Clinical Ophthalmology Basel (IOB)</institution>, <addr-line>4031 Basel</addr-line>, <country country="CH">Switzerland</country></aff>
          <aff>
<institution>Department of Ophthalmology</institution>, University of Basel, <addr-line>4031 Basel</addr-line>, <country country="CH">Switzerland</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>McGrath</surname>
            <given-names>John A</given-names>
          </name>
          <!--john.mcgrath@kcl.ac.uk-->
          <aff>
<institution>NIHR Biomedical Research Centre</institution>, Guy's and St Thomas' NHS Foundation Trust and King's College London, London SE1 9RT, <country country="GB">UK</country></aff>
          <aff>
<institution>St John's Institute of Dermatology</institution>, King's College London (Guy's campus), <addr-line>London SE1 9RT</addr-line>, <country country="GB">UK</country></aff>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Moss</surname>
            <given-names>Celia</given-names>
          </name>
          <!--celia.moss@nhs.net-->
          <aff>
<institution>Department of Paediatric Dermatology</institution>, Birmingham Women&#x2019;s and Children&#x2019;s Hospital NHS FT, <addr-line>Birmingham B4 6NH</addr-line>, <country country="GB">UK</country></aff>
          <aff>
<institution>College of Medical and Dental Sciences</institution>, University of Birmingham, <addr-line>Birmingham B15 2TT</addr-line>, <country country="GB">UK</country></aff>
          <xref rid="afn1" ref-type="author-notes"/>
          <xref rid="cor1" ref-type="corresp"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Rivolta</surname>
            <given-names>Carlo</given-names>
          </name>
          <!--carlo.rivolta@iob.ch-->
          <aff>
<institution>Institute of Molecular and Clinical Ophthalmology Basel (IOB)</institution>, <addr-line>4031 Basel</addr-line>, <country country="CH">Switzerland</country></aff>
          <aff>
<institution>Department of Ophthalmology</institution>, University of Basel, <addr-line>4031 Basel</addr-line>, <country country="CH">Switzerland</country></aff>
          <aff>
<institution>Department of Genetics and Genome Biology</institution>, University of Leicester, <addr-line>Leicester LE1 7RH</addr-line>, <country country="GB">UK</country></aff>
          <xref rid="afn1" ref-type="author-notes"/>
          <xref rid="cor1" ref-type="corresp"/>
        </contrib>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">To whom correspondence should be addressed at: For clinical inquiries, Department of Paediatric Dermatology, Birmingham Women&#x2019;s and Children&#x2019;s Hospital NHS FT, Birmingham B4 6NH, UK. Tel: <phone>+44-121-333-8225</phone>; Email: <email>celia.moss@nhs.net</email>; For genetic inquiries, Clinical Research Center, Institute of Molecular and Clinical Ophthalmology Basel (IOB), Mittlere Strasse 91, Basel 4031, Switzerland. Tel: <phone>+41-61-265-9214</phone>; Email: <email>carlo.rivolta@iob.ch</email></corresp>
        <fn id="afn1">
          <p>Equal contribution</p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <day>15</day>
        <month>6</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="epub" iso-8601-date="2022-01-06">
        <day>06</day>
        <month>1</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>06</day>
        <month>1</month>
        <year>2022</year>
      </pub-date>
      <volume>31</volume>
      <issue>12</issue>
      <fpage>1970</fpage>
      <lpage>1978</lpage>
      <history>
        <date date-type="received">
          <day>19</day>
          <month>7</month>
          <year>2021</year>
        </date>
        <date date-type="rev-recd">
          <day>18</day>
          <month>11</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>12</month>
          <year>2021</year>
        </date>
        <date date-type="corrected-typeset">
          <day>01</day>
          <month>2</month>
          <year>2022</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2022. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com</copyright-statement>
        <copyright-year>2022</copyright-year>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="ddab368.pdf"/>
      <abstract>
        <title>Abstract</title>
        <p>In the framework of the UK 100&#x2009;000 Genomes Project, we investigated the genetic origin of a previously undescribed recessive dermatological condition, which we named LIPHAK (LTV1-associated Inflammatory Poikiloderma with Hair abnormalities and Acral Keratoses), in four affected individuals from two UK families of Pakistani and Indian origins, respectively. Our analysis showed that only one gene, <italic toggle="yes">LTV1</italic>, carried rare biallelic variants that were shared in all affected individuals, and specifically they bore the NM_032860.5:c.503A&#x2009;&gt;&#x2009;G, p.(Asn168Ser) change, found homozygously in all of them. In addition, high-resolution homozygosity mapping revealed the presence of a small 652-kb stretch on chromosome 6, encompassing <italic toggle="yes">LTV1</italic>, that was haploidentical and common to all affected individuals. The c.503A&#x2009;&gt;&#x2009;G variant was predicted by <italic toggle="yes">in silico</italic> tools to affect the correct splicing of <italic toggle="yes">LTV1</italic>&#x2019;s exon 5. Minigene-driven splicing assays in HEK293T cells and in a skin sample from one of the patients confirmed that this variant was indeed responsible for the creation of a new donor splice site, resulting in aberrant splicing and in a premature termination codon in exon 6 of this gene. <italic toggle="yes">LTV1</italic> encodes one of the ribosome biogenesis factors that promote the assembly of the small (40S) ribosomal subunit. In yeast, defects in <italic toggle="yes">LTV1</italic> alter the export of nascent ribosomal subunits to the cytoplasm; however, the role of this gene in human pathology is unknown to date. Our data suggest that LIPHAK could be a previously unrecognized ribosomopathy.</p>
      </abstract>
      <funding-group>
        <award-group award-type="grant">
          <funding-source>
<institution-wrap><institution>Swiss National Science Foundation</institution><institution-id institution-id-type="DOI">10.13039/501100001711</institution-id></institution-wrap>
</funding-source>
          <award-id>176097</award-id>
        </award-group>
      </funding-group>
      <counts>
        <page-count count="9"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="sec1">
      <title>Introduction</title>
      <p>Poikiloderma is an unusual skin condition comprising pigmentation, telangiectasia and atrophy. It occurs in several rare genetic disorders with disparate pathogenesis including Kindler epidermolysis bullosa (OMIM #173650, a disorder of epithelial adhesion), Rothmund Thomson syndrome (OMIM #268400, a DNA repair disorder), dyskeratosis congenita (a group of telomeropathies) and poikiloderma with neutropenia (OMIM #604173, a disorder linked to maturation of U6 snRNA) (<xref rid="ref1" ref-type="bibr">1</xref>). These can sometimes be differentiated clinically by the distribution of poikiloderma and associated features, but genetic analysis is diagnostic.</p>
      <p>The ribosome is the key element of translation, an essential biological process producing proteins from messenger RNA (mRNA). In eukaryotes, it is composed of a 40S (small) and a 60S (large) subunit (<xref rid="ref2" ref-type="bibr">2&#x2013;4</xref>). The synthesis of pre-40S subunits begins with folding of ribosomal RNA (rRNA), followed by recruitment of ribosomal proteins (RPs) and assembly factors (AFs) in the nucleolus. Low temperature viability protein 1 (LTV1) is one of these AFs. It interacts with RPs, chaperoning the correct ribosomal assembly (<xref rid="ref5" ref-type="bibr">5</xref>,<xref rid="ref6" ref-type="bibr">6</xref>), and promotes the nuclear export of pre-40S into the cytoplasm (<xref rid="ref7" ref-type="bibr">7</xref>,<xref rid="ref8" ref-type="bibr">8</xref>). In yeast, Ltv1 mutations lead to reduced recruitment of some RPs to the ribosomal complex, which in turn introduces defects in translational fidelity (<xref rid="ref5" ref-type="bibr">5</xref>,<xref rid="ref9" ref-type="bibr">9</xref>,<xref rid="ref10" ref-type="bibr">10</xref>). According to the mouse genome informatics database (MGI) (<xref rid="ref11" ref-type="bibr">11</xref>), ablation of the <italic toggle="yes">Ltv1</italic> gene in mouse results in preweaning lethality, but so far no <italic toggle="yes">LTV1</italic>-related phenotypes have been described in humans.</p>
      <p>Using whole-genome sequencing (WGS), here we identify a mutation in <italic toggle="yes">LTV1</italic> [NM_032860.5, c.503A&#x2009;&gt;&#x2009;G, p.(Asn168Ser)] as the likely molecular cause for a previously unreported poikilodermatous recessive condition, in four patients from two different families. <italic toggle="yes">In vitro</italic>, this exonic DNA variant results in two different transcripts: a minor form carrying the p.(Asn168Ser) substitution (~11% of transcribed RNA, with respect to control) and a major form being aberrantly spliced and presumably degraded by nonsense-mediated mRNA decay (NMD) <italic toggle="yes">in vivo</italic>.</p>
    </sec>
    <sec id="sec2">
      <title>Results</title>
      <sec id="sec3">
        <title>Family 1: Patients 1, 2 and 3</title>
        <p>Patients 1 (II.4), 2 (II.3) and 3 (II.2) were sisters of Pakistani origin (<xref rid="f1" ref-type="fig">Fig. 1A</xref>). They also had one unaffected sister and their parents were first cousins with no other relevant family history. They were first examined aged 2, 7 and 10&#xA0;years, respectively and have been followed up for 20&#xA0;years.</p>
        <fig position="float" id="f1">
          <label>Figure 1</label>
          <caption>
            <p>Pedigrees analyzed<bold>.</bold> (<bold>A</bold>) Family 1 originates from Pakistan and consists of parents who are first cousins, as well as four daughters, three of whom are affected. (<bold>B</bold>) Family 2, originating from India. Parents are unrelated. Their only daughter is affected. M: NM_032860.5, c.503A&#x2009;&gt;&#x2009;G:p.(Asn168Ser); +, WT allele.</p>
          </caption>
          <graphic xlink:href="ddab368f1" position="float"/>
        </fig>
        <p>Patient 1, at 2&#xA0;years, had striking livedoid erythema in a reticulate pattern particularly marked on the limbs (<xref rid="f2" ref-type="fig">Fig. 2A</xref>). In some areas the erythema was scaly, atrophic and pigmented, with small, discrete patches of hypopigmentation in the spaces within the reticulate network (<xref rid="f2" ref-type="fig">Fig. 2B</xref>). The upper trunk was largely spared but lower trunk, flanks and forehead were affected with mottled hyper- and hypopigmentation as were palms and soles (<xref rid="f2" ref-type="fig">Fig. 2C and D</xref>). Eyebrows were absent and eyelashes were sparse, scalp hair was normal in texture but generally sparse and there were no other ectodermal or haematological or other abnormalities. Ophthalmoscopy revealed asymptomatic embryonal nuclear cataracts. Skin biopsy from the thigh at age 3&#xA0;years showed a mild lichenoid lymphocytic infiltrate in the papillary dermis with melanophage accumulation and pigmentary incontinence.</p>
        <fig position="float" id="f2">
          <label>Figure 2</label>
          <caption>
            <p>Clinical synopsis. (<bold>A</bold>) Patient 1, aged 2.5&#xA0;years, showing the distribution skin changes. (<bold>B</bold>) Morphology of skin changes in (left to right) Patient 1 at 2.5 and 14&#xA0;years and Patient 4 at 21&#xA0;years. (<bold>C</bold>) Palms of Patient 1 (left), aged 2.5 and 7&#xA0;years, and of Patient 4 (right) aged 11 and 21&#xA0;years, showing reticulate pigmentation, progressive scaling and peripheral keratoses. (<bold>D</bold>) Feet of Patient 1 (left) aged 14&#xA0;years and of Patient 4 (right) aged 11&#xA0;years.</p>
          </caption>
          <graphic xlink:href="ddab368f2" position="float"/>
        </fig>
        <p>Patient 2, at 7&#xA0;years, had mottled hyper- and hypopigmentation distributed as in her younger sister but with no erythema. She also has asymptomatic embryonal nuclear cataracts. Her palms and soles showed scaling. The other features were the same, including absent eyebrows, except that her scalp hair was normal.</p>
        <p>Patient 3, at 10&#xA0;years, had similar skin changes to patient 2; her eyebrows were absent and scalp hair was thin in patches. She had peripheral plantar keratoses. Ophthalmic examination was normal.</p>
        <p>By 14&#xA0;years all three had mottled hyper- and hypopigmentation and peripheral punctate plantar keratoses (<xref rid="f2" ref-type="fig">Fig. 2D</xref>). Now aged 21, 26 and 30&#xA0;years, they remain healthy and the pigmentary changes have faded considerably but remain most marked in Patient 1. Eyebrows remain absent and have been replaced by cosmetic tattoos. They avoid sun exposure which causes redness within 2&#xA0;h and makes the pigmentary changes more obvious. Acral scaling and punctate keratoses persist. In all three growth, development and general health have been normal.</p>
      </sec>
      <sec id="sec4">
        <title>Family 2: Patient 4</title>
        <p>Patient 4 (II.1) is the only child of unrelated parents whose families originate from Gujarat in India with no relevant family history (<xref rid="f1" ref-type="fig">Fig. 1B</xref>). Her growth and development were normal with no haematological abnormalities. Skin changes started acrally at 6&#xA0;months of age and progressed proximally. At age 6 and 9&#xA0;years she had mottled hyper- and hypopigmentation affecting the face, buttocks and limbs including palmar and plantar surfaces with reticulate scaly erythema on the extremities. Her hair and eyelashes were sparse, as were eyebrows especially laterally. When last examined at age 18&#xA0;years she had mottled hyper- and hypopigmentation and acral keratoderma with the same appearance and distribution as in Patients 1&#x2013;3 (<xref rid="f2" ref-type="fig">Fig. 2B&#x2013;D</xref>). She had dry skin generally but no other ectodermal or systemic abnormalities.</p>
        <p>A skin biopsy from the ankle region at age 4&#xA0;years showed hyperkeratosis and focal parakeratosis. A mild superficial dermal chronic inflammatory infiltrate extended focally into the epidermal basal layer with some basal keratinocyte vacuolation. The papillary dermis showed scattered melanophages and focal vascular dilatation. Direct immunofluorescence showed no significant deposition of immunoglobulins, C3 or fibrin and no lupus band.</p>
      </sec>
      <sec id="sec5">
        <title>Genetic findings</title>
        <p>Genetic testing for Rothmund Thompson syndrome and Kindler syndrome was negative in both families. Primary analysis of results from PanelApp (<xref rid="ref12" ref-type="bibr">12</xref>) virtual gene panels applied to WGS data (<xref rid="TB1" ref-type="table">Table 1</xref>), on the basis of Human Phenotype Ontology (HPO) terms entered (<xref rid="ref13" ref-type="bibr">13</xref>), did not identify any variants considered to be causative of the phenotype.</p>
        <table-wrap position="float" id="TB1">
          <label>Table 1</label>
          <caption>
            <p>Virtual PanelApp gene panels applied to each case as part of the 100&#x2009;000 Genomes Project on the basis of HPO terms entered for cases</p>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col align="left" span="1"/>
              <col align="left" span="1"/>
              <col align="left" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">
<bold>Case</bold>
</th>
                <th align="left" rowspan="1" colspan="1">1, 2 and 3</th>
                <th align="left" rowspan="1" colspan="1">4</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">
<bold>Panels applied</bold>
</td>
                <td align="left" rowspan="1" colspan="1">Erythropoietic protoporphyria, mild variant v1.2<break/>Palmoplantar keratoderma and erythrokeratodermas v1.15</td>
                <td align="left" rowspan="1" colspan="1">Palmoplantar keratoderma and erythrokeratodermas v1.16<break/>Erythropoietic protoporphyria, mild variant v1.2<break/>Hydroa vacciniforme v1.2<break/>Hereditary haemorrhagic telangiectasia v1.51</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>We therefore utilized a gene-agnostic approach, filtering for variants in genes that segregated with disease in the affected family members and at a low population frequency (see Methods). This led to the identification of only one candidate variant, present in the <italic toggle="yes">LTV1</italic> gene. The variant, NM_032860.3:c.503A&#x2009;&gt;&#x2009;G: p.(Asn168Ser) in exon 5, was present homozygously in all four affected individuals from both families and heterozygously in parents from both pedigrees (<xref rid="f1" ref-type="fig">Fig. 1</xref>). In the gnomAD database (<xref rid="ref14" ref-type="bibr">14</xref>), this variant was reported only once in a subject of European origin, in a heterozygous state, over a total of 251&#x2009;344 analyzed alleles (allele frequency&#x2009;=&#x2009;3.98 &#xD7; 10<sup>&#x2212;6</sup>), of which 30&#x2009;614 were from South Asian individuals. Most of the standard pathogenicity software, including SIFT (<xref rid="ref15" ref-type="bibr">15</xref>) and PolyPhen-2 (<xref rid="ref16" ref-type="bibr">16</xref>), predicted the missense change to be benign. However, algorithms evaluating potential impact on splicing, such as SpliceAI (<xref rid="ref17" ref-type="bibr">17</xref>) and MaxEntScan (<xref rid="ref18" ref-type="bibr">18</xref>), detected that the A&#x2009;&gt;&#x2009;G transition could result in the creation of a new donor splice site. This new site could compete with the correct one, resulting in the truncation of 37&#xA0;bp at the 3&#x2032; side of exon 5 by virtue of its premature fusion with exon 6, and this event would in turn lead to a frameshift and a premature termination codon in exon 6: p.(Asn168ArgfsTer47). Moreover, autozygosity mapping (<xref rid="ref19" ref-type="bibr">19</xref>) showed that this variant was comprised within a small region of homozygosity (652 kb) that was common to all patients and was also haploidentical (<xref rid="sup3" ref-type="supplementary-material">Supplementary Material, Table S1</xref>, <xref rid="sup1" ref-type="supplementary-material">Supplementary Material, Fig. S1</xref>), implying that the mutation in the two families did not arise independently but was likely inherited from a common ancestor.</p>
        <!--<fig id="f3">
<label>Supplementary Table S1</label>
<graphic mimetype="image" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ddab368f3.tif"/>
</fig>
<fig id="f4">
<label>Supplementary Figure S1</label>
<graphic mimetype="image" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ddab368f4.tif"/>
</fig>-->
      </sec>
      <sec id="sec6">
        <title>Splicing assays</title>
        <p>To investigate the potential role on splicing of the variant detected, we designed a minigene composed of exon 5, intron 5 and exon 6 of <italic toggle="yes">LTV1</italic>, either including the wild-type (WT) or alternative genotype at position c.503, within exon 5. Following RNA purification, complementary DNA (cDNA) synthesis and reverse transcription polymerase chain reaction (RT-PCR), we then assessed the splicing patterns of both minigenes in transfected HEK293T cells. In addition to displaying small amounts of canonically spliced transcripts (estimated by capillary electrophoresis to represent ~&#x2009;11% of all minigene-derived RNA), minigenes carrying the c.503A&#x2009;&gt;&#x2009;G change resulted mostly into an aberrant and shorter RNA form, in which exon 5 was prematurely fused to exon 6, exactly as predicted <italic toggle="yes">in silico</italic> by the software mentioned above (<xref rid="f3" ref-type="fig">Fig. 3</xref>). RNA bearing this rearrangement, leading to the shift of the reading frame and the creation of a premature termination codon, would probably be subject to NMD in <italic toggle="yes">in vivo</italic> conditions. Of note, this aberrant form was not present in RNA from cells transfected with WT minigenes, as demonstrated by using RT-PCR primers specific for this alternative transcript (<xref rid="f3" ref-type="fig">Fig. 3A</xref>).</p>
        <fig position="float" id="f3">
          <label>Figure 3</label>
          <caption>
            <p>Molecular analysis. (<bold>A</bold>) Gel electrophoresis of the RT-PCR products from HEK293T cells transfected with minigene plasmids carrying exon 5 to exon 6 of <italic toggle="yes">LTV1</italic> and either the WT allele or the c.503A&#x2009;&gt;&#x2009;G mutation. The mutant form of the plasmid has two transcripts, corresponding to the correctly spliced isoform (1) and an aberrantly spliced isoform (2). This non-canonical transcript (2,3) is present only in cells transfected with minigenes bearing the mutation, as specifically shown by the use of an isoform-specific primer (CR 7326). (<bold>B</bold>) Sanger sequencing of the two transcripts, from the WT minigene (top) and the one carrying c.503A&#x2009;&gt;&#x2009;G (bottom). (<bold>C</bold>) Schematic view of the <italic toggle="yes">LTV1</italic> minigene, depicting the position of the variant identified and the splicing event resulting from its presence, as well as the position of the PCR primers used.</p>
          </caption>
          <graphic xlink:href="ddab368f3" position="float"/>
        </fig>
        <p>These results were corroborated by semi-quantitative RT-PCR analysis of <italic toggle="yes">LTV1</italic> in a skin sample from Patient 4, showing reduced expression compared with control skin. cDNA sequencing across the site of the mutation also confirmed the aberrant splicing (<xref rid="sup2" ref-type="supplementary-material">Supplementary Material, Fig. S2</xref>).</p>
        <!--<fig id="f6">
<label>Supplementary Figure S2</label>
<graphic mimetype="image" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ddab368f6.tif"/>
</fig>-->
      </sec>
      <sec id="sec7">
        <title>Immunofluorescence microscopy</title>
        <p>We then analyzed LTV1 protein expression and distribution in a skin biopsy from Patient 4 and a control. In control skin, expression of LTV1 was noted within the basal keratinocyte layer of the epidermis (<xref rid="f4" ref-type="fig">Fig. 4</xref>). There was diffuse cytoplasmic staining with granular perinuclear accentuation across the basal layer. In contrast, in patient skin the intensity of the labelling was slightly reduced (<xref rid="f4" ref-type="fig">Fig. 4</xref>). In addition, the pattern of staining within the basal layer was uneven with some basal keratinocytes showing near normal intensity labelling, whereas other basal keratinocytes showed markedly reduced immunostaining for LTV1.</p>
        <fig position="float" id="f4">
          <label>Figure 4</label>
          <caption>
            <p>Immunostaining of LTV1 in control and patient skin. (<bold>A</bold>) In control skin there is diffuse cytoplasmic staining within the basal keratinocytes, with additional granular perinuclear labelling seen at higher magnification. The intensity of the staining is evenly distributed along the basal keratinocyte layer within the skin section. (<bold>B</bold>) In patient skin, the immunoreactivity for LTV1 is slightly reduced. Of note, staining along the basal layer is uneven with some basal keratinocytes showing barely any immunostaining.</p>
          </caption>
          <graphic xlink:href="ddab368f4" position="float"/>
        </fig>
      </sec>
    </sec>
    <sec id="sec8">
      <title>Discussion</title>
      <p>We report on four affected individuals from two pedigrees, all bearing a common homozygous mutation in the gene <italic toggle="yes">LTV1</italic> and presenting with a homogeneous and recessive phenotype of poikiloderma associated with palmoplantar keratoses and sparse eyebrows, which we termed LIPHAK syndrome (LTV1-associated Inflammatory Poikiloderma with Hair abnormalities and Acral Keratoses). <italic toggle="yes">In vitro</italic> and <italic toggle="yes">in vivo</italic>, this variant results in a splicing defect, which in turn leads to a shift of the reading frame and to the creation of a premature termination codon. Because of its position within the primary sequence of <italic toggle="yes">LTV1</italic> pre-mRNA, this stop codon should lead <italic toggle="yes">in vivo</italic> to the active degradation of all transcripts that bear it, by the action of the NMD machinery (<xref rid="ref20" ref-type="bibr">20</xref>). Importantly, no additional putatively pathogenic variant that was common to both families was detected, within the ROHs shared by the affected individuals or elsewhere.</p>
      <p>The skin condition displayed by these patients does not entirely fit the term &#x2018;poikiloderma&#x2019;. Telangiectasia and atrophy were limited and in the adults only hyper- and hypopigmentation remained. A more accurate but less concise term might be &#x2018;reticulate poikilodermatous dyschromatosis&#x2019;. The initial livedo reticularis-like pattern suggests cutaneous vasculopathy with impaired oxygenation at the periphery of arteriolar supply zones. The subsequent pigmentation may be post-inflammatory, but the final pattern of discrete hyper- and hypopigmented macules is less obviously reticulate and resembles the dyschromatosis seen in familial progressive hyper- and hypopigmentation (OMIM #145250) caused by dominant mutations in <italic toggle="yes">KITLG</italic> (<xref rid="ref21" ref-type="bibr">21</xref>).</p>
      <p>Ribosomal subunits undergo a series of processing, modifications and final maturation to be competent for protein synthesis (<xref rid="ref22" ref-type="bibr">22</xref>). In yeast, the Ltv1 protein has been found to be central for the correct assembly and functioning of ribosomes (<xref rid="ref7" ref-type="bibr">7</xref>,<xref rid="ref9" ref-type="bibr">9</xref>,<xref rid="ref10" ref-type="bibr">10</xref>,<xref rid="ref23" ref-type="bibr">23</xref>), whereas its function in human biology has not been fully investigated. The role of Ltv1 is particularly important for biogenesis of the 40S subunit, which involves the interaction of the two 18S rRNA helices (h16 and h41) with other proteins, such as for instance Enp1 and Rps3 (<xref rid="ref22" ref-type="bibr">22</xref>,<xref rid="ref24" ref-type="bibr">24</xref>). These interactions induce structural rearrangement during the final maturation of small subunits and the stable incorporation of remaining RPs and AFs (<xref rid="ref5" ref-type="bibr">5</xref>,<xref rid="ref25" ref-type="bibr">25</xref>). In humans, Hrr25-like protein kinases, including CK1&#x3B4;/&#x3B5;, phosphorylate LTV1 to dissociate it from AFs of the subunit (<xref rid="ref9" ref-type="bibr">9</xref>,<xref rid="ref26" ref-type="bibr">26</xref>). Ltv1 mutants, in yeast and <italic toggle="yes">Drosophila</italic>, show reduced cell growth (<xref rid="ref6" ref-type="bibr">6</xref>,<xref rid="ref9" ref-type="bibr">9</xref>).</p>
      <p>Our <italic toggle="yes">in vitro</italic> results indicate that c.503A&#x2009;&gt;&#x2009;G, while leading mostly to aberrant mRNA, does not prevent completely the correct splicing of <italic toggle="yes">LTV1</italic> pre-mRNA. Therefore, the patients described here, homozygous for this mutation, are likely to produce fully functional LTV1 protein, although in reduced amounts. Noteworthy, knockout mice for LTV1 die before weaning age, implying that LTV1 protein is required for survival (<xref rid="ref11" ref-type="bibr">11</xref>). <italic toggle="yes">LTV1</italic> has not previously been linked to any genetic diseases. It is expressed in &gt;200 tissues with no particular tissue specificity, as shown in GTEx (<ext-link xlink:href="https://www.gtexportal.org/home/gene/LTV1" ext-link-type="uri">https://www.gtexportal.org/home/gene/LTV1</ext-link>) (<xref rid="ref27" ref-type="bibr">27</xref>), and its encoded protein is found in both the cytosol and the nucleoplasm. Expression of LTV1 has been noted as an unfavourable prognostic marker in renal and liver cancer (<ext-link xlink:href="https://www.proteinatlas.org/ENSG00000135521-LTV1/pathology" ext-link-type="uri">https://www.proteinatlas.org/ENSG00000135521-LTV1/pathology</ext-link>), but there is no known association with skin disease. Conceivably, however, this disruption of ribosome function may be more marked in tissues displaying increased oxidative stress, such as the skin. Thus, it is plausible that the poikiloderma and other features observed in our cases represent a kind of ribosomopathy, where a slight impairment of ribosome assembly can cause a mild translation defect, but only in specific cells (including certain skin cells). Another rare and syndromic poikilodermatous condition, dyskeratosis congenita (OMIM #305000), characterized by irreversible degeneration of skin tissue and bone marrow failure (<xref rid="ref28" ref-type="bibr">28</xref>,<xref rid="ref29" ref-type="bibr">29</xref>), while generally considered a telomeropathy, also has features of a ribosomopathy (<xref rid="ref30" ref-type="bibr">30</xref>). It is caused by mutations in <italic toggle="yes">DKC1</italic> and the encoded protein, dyskerin, is involved in the maturation of rRNAs (<xref rid="ref31" ref-type="bibr">31</xref>). An alternative, or perhaps additional explanation is that the <italic toggle="yes">LTV1</italic> mutation may impair a different cellular process altogether, for example the early endosome recycling (<xref rid="ref32" ref-type="bibr">32</xref>). Although complex and diverse, abnormalities in endosome recycling pathways in skin cells have been implicated in certain inherited skin diseases, namely some forms of epidermolysis bullosa and Griscelli syndrome (<xref rid="ref33" ref-type="bibr">33</xref>,<xref rid="ref34" ref-type="bibr">34</xref>).</p>
      <p>In summary, we describe a novel autosomal recessive skin disorder characterized by a reticulate poikilodermatous dyschromatosis and apparently caused by a homozygous splice variant in <italic toggle="yes">LTV1</italic>, categorizing it as a probable ribosomopathy. Additional research in animal models or identification of other individuals segregating <italic toggle="yes">LTV1</italic> biallelic variants will be important to better understand the molecular pathology of this condition.</p>
    </sec>
    <sec id="sec9">
      <title>Materials and Methods</title>
      <sec id="sec10">
        <title>Patients and families</title>
        <p>This study was performed in agreement with the tenets of the Declaration of Helsinki, following the signature of written informed consent forms (including the use of images) by the patients and their family members and the approval by the UK Health Research Authority and the Ethikkommission Nordwest- und Zentralschweiz. Families 1 and 2 were identified in routine dermatological practice and their unique but shared phenotype was noted in 2005. In 2017, in the absence of a molecular diagnosis, both families were recruited to the UK 100&#x2009;000 Genomes Project (<xref rid="ref35" ref-type="bibr">35</xref>). Consent was also obtained for WGS and further research.</p>
      </sec>
      <sec id="sec11">
        <title>WGS</title>
        <p>WGS was performed in all affected individuals and their parents as part of the 100&#x2009;000 Genomes Project. Blood samples, consent, clinical indication, and HPO terms were collected for patients at local hospitals. Blood samples were sent to regional genetics laboratories and DNA extracted, which was sent on to Illumina for WGS. Library preparation was performed using TruSeq DNA PCR-Free Library Prep, with 150&#xA0;bp paired-end reads generated from the HiSeqX sequencer. Data were passed through Genomics England&#x2019;s bioinformatics pipeline. Variants were filtered on the basis of quality control, allele frequency, functional impact and segregation in affected family members (<xref rid="ref36" ref-type="bibr">36</xref>).</p>
      </sec>
      <sec id="sec12">
        <title>Autozygome and haplotype analysis</title>
        <p>Runs of homozygosity (ROH) regions were investigated for each individual using AutoMap (<xref rid="ref19" ref-type="bibr">19</xref>) (parameters: minimal size of ROH&#x2009;&#x2265;&#x2009;0.5&#xA0;Mb, minimal number of homozygous variant in window &#x2265;15, minimal percentage of homozygous variant &#x2265;90) and then combined <italic toggle="yes">in silico</italic>.</p>
        <p>Haplotypes spanning the <italic toggle="yes">LTV1</italic> region were assessed by retaining variants of good quality only (genotype quality &#x2265;50 in the Variant Call Format (VCF) file), and their frequencies were obtained from dbSNP (<xref rid="ref37" ref-type="bibr">37</xref>). Genotypes in polyA tails of pseudogenes were excluded from the analysis.</p>
      </sec>
      <sec id="sec13">
        <title>In silico analysis of variants</title>
        <p>DNA variants were obtained from VCFs present in the 100&#x2009;000 Genomes Project (<xref rid="ref35" ref-type="bibr">35</xref>). For assessment of mutations, only variants with an allele frequency of 0.01 or lower, as reported by the gnomAD database (<xref rid="ref14" ref-type="bibr">14</xref>), were retained. Missense changes were analyzed using an <italic toggle="yes">in silico</italic> pipeline developed internally (<xref rid="ref38" ref-type="bibr">38</xref>).</p>
      </sec>
      <sec id="sec14">
        <title>Minigene-driven splicing assay</title>
        <p>To assess the effect of the c.503A&#x2009;&gt;&#x2009;G variant on pre-mRNA splicing, minigene-driven assay was performed, as aforementioned (<xref rid="ref39" ref-type="bibr">39</xref>). Briefly, the <italic toggle="yes">LTV1</italic> exon5&#x2013;intron5&#x2013;exon6 genomic sequences from an affected individual and a control were polymerase chain reaction (PCR)-amplified with gene-specific primers containing the recombination sites attB1 and attB2 at their 5&#x2032; ends (Forward CR7267, 5&#x2032;-ggggacaagtttgtacaaaaaagcaggctgacctcgactggattttgat-3&#x2032;; Reverse CR7268, 5&#x2032;-ggggaccactttgtacaagaaagctgggtctatcttctcaaacctctcatcat-3&#x2032;). After PCR amplification, purified PCR products were cloned into a Gateway&#x2122; pDEST&#x2122;26 Vector (Thermo Fisher Scientific). The DNA sequence of both resulting WT and mutant minigenes was confirmed to be correct by direct Sanger sequencing.</p>
        <p>Plasmids bearing minigenes were transfected into HEK293T cells using FuGENE HD (Promega) in duplicates. Cells were harvested 24&#xA0;h after transfection and total RNA was extracted using the QuickPrep total RNA extraction kit (GE Healthcare). cDNA was obtained by using a High Capacity cDNA Reverse Transcription kit (Applied Biosystems), following manufacturer&#x2019;s protocols and used as a template for PCR amplification using a vector-specific attB1 forward primer (Forward CR7320, 5&#x2032;-caacaagtttgtacaaaaaagcaggc-3&#x2032;) in combination with either a reverse primer matching <italic toggle="yes">LTV1</italic> exon 6 (Reverse CR7323, 5&#x2032;-gctatctcccttctcatcatccac-3) or a reverse primer matching the aberrant exon5&#x2013;exon6 junction elicited by c.503A&#x2009;&gt;&#x2009;G and described below (Reverse CR7326, 5&#x2032;-cctgttgcctctcctgttg-3). The resulting amplified fragments were displayed on a 2% agarose gel and analyzed by a QIAxcel instrument (Qiagen). Quantification of RT-PCR products separated by capillary electrophoresis was achieved by integrating the area under each peak. All products resulting from cDNA amplification were Sanger-sequenced.</p>
      </sec>
      <sec id="sec15">
        <title>Skin biopsy and immunofluorescence microscopy</title>
        <p>Following written consent, an ellipse skin biopsy was obtained under local anaesthetic. The skin was snap frozen and 4&#xA0;mm sections were then cut, mounted on glass slides, and allowed to dry. Sections were washed in phosphate-buffered saline (PBS; Sigma P4417, Lot SLCH5832) and then covered in 10% normal donkey serum (Sigma Aldrich G9023, Lot SLCK7210) before this was removed and the sections were exposed to the LTV1 antibody (Polyclonal rabbit anti LTV1; Abcam ab122100, Lot GR116961&#x2013;8) diluted 1 in 25 in 1% bovine serum albumin (Sigma A2153, Lot SLCB5832) diluted in PBS and then incubated at 37&#xB0;C for 1&#xA0;h. Negative controls omitted the primary antibody. The sections were then washed twice in PBS and covered with fluorescently labelled secondary antibody (DaR AF488: Donkey anti Rabbit Alexa Fluor 488; Abcam ab150061, Lot GR3350992&#x2013;3, diluted 1 in 500) and then incubated at 37&#xB0;C for 1&#xA0;h, before further washing in PBS. The sections were then cover slipped using Vectorshield with 4',6-diamidino-2-phenylindole (DAPI) as a mountant. The slides were viewed using an Olympus BX63 microscopy and photographed at an exposure of 127&#xA0;ms (AF488) 2.49&#xA0;ms (DAPI).</p>
      </sec>
      <sec id="sec16">
        <title>Semi-quantitative RT-PCR</title>
        <p>From part of the skin biopsy, RNA was extracted using QIAGEN RNeasy Fibrous Tissue Mini kit (74704). Next, 100 ul of cDNA was converted from RNA extracted from 0.3 mm<sup>3</sup> skin tissue, using Invitrogen SuperScript III First-Strand cDNA Synthesis System. For semi-Q-PCR, a multiplex PCR system with the target and the housekeeping gene <italic toggle="yes">GAPDH</italic> was designed and optimized to obtain the best-balanced efficiency between these two PCR products. Five PCR cycling points (cycle 20, 24, 28, 32 and 36) were checked to ensure that the measurements would fall within the PCR exponential phase. Each point was assessed in triplicate, and gel images were quantified using ImageJ. To assess cDNA expression, <italic toggle="yes">LTV1</italic> primers were designed to amplify part of the gene within its 3&#x2032;UTR: LTV1-cDNA-F, AAGGACTCACAGCAAAGCAAA; LTV1-cDNA-R, AAGGACTCACAGCAAAGCAAA. To assess the impact of the missense mutation on splicing, the following <italic toggle="yes">LTV1</italic> primers were used: LTV1-c.503-C-F, GTTGCCTTCATCAGTGTTTGC; LTV1-c.503-C-R, ACATCTTCCCACTCGCTGTC.</p>
      </sec>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary Material</title>
      <supplementary-material id="sup1" position="float" content-type="local-data">
        <label>Figure_S1_ddab368</label>
        <media xlink:href="figure_s1_ddab368.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material id="sup2" position="float" content-type="local-data">
        <label>Figure_S2_ddab368</label>
        <media xlink:href="figure_s2_ddab368.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material id="sup3" position="float" content-type="local-data">
        <label>Supplementary_Table_1_ddab368</label>
        <media xlink:href="supplementary_table_1_ddab368.xlsx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack id="ddab368-ack">
      <title>Acknowledgements</title>
      <p>We are grateful to Sasi Conte (King&#x2019;s College London), Ed Hurt (University of Heidelberg) and Deborah Lycan (Lewis and Clark College, Portland) for helpful discussions on the potential disease relevance of the <italic toggle="yes">LTV1</italic> variant. This research was made possible through access to the data and findings generated by the 100&#x2009;000 Genomes Project. The 100&#x2009;000 Genomes Project is managed by Genomics England Limited (a wholly owned company of the Department of Health and Social Care). The 100&#x2009;000 Genomes Project is funded by the National Institute for Health Research and NHS England. The Wellcome Trust, Cancer Research UK and the Medical Research Council have also funded research infrastructure. The 100&#x2009;000 Genomes Project uses data provided by patients and collected by the National Health Service as part of their care and support.</p>
      <p>
<italic toggle="yes">Conflict of Interest statement</italic>. None declared.</p>
    </ack>
    <sec sec-type="data-availability" id="sec17">
      <title>Data Availability</title>
      <p>The data to support the findings of this study are available from the corresponding author upon request.</p>
    </sec>
    <sec id="sec19">
      <title>Funding</title>
      <p>Swiss National Science Foundation (grant no. 204285 to C.R.).</p>
    </sec>
    <ref-list id="bib1">
      <title>References</title>
      <ref id="ref1">
        <label>1</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Rayinda</surname>, <given-names>T.</given-names></string-name>, <string-name><prefix>van</prefix><surname>Steensel</surname>, <given-names>M.</given-names></string-name> and <string-name><surname>Danarti</surname>, <given-names>R.</given-names></string-name></person-group> (<year>2021</year>) <article-title>Inherited skin disorders presenting with poikiloderma</article-title>. <source>Int. J. Dermatol.</source>, <volume>60</volume>, <fpage>1343</fpage>&#x2013;<lpage>1353</lpage>.<pub-id pub-id-type="pmid">33739439</pub-id></mixed-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ben-Shem</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Garreau de Loubresse</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Melnikov</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Jenner</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Yusupova</surname>, <given-names>G.</given-names></string-name> and <string-name><surname>Yusupov</surname>, <given-names>M.</given-names></string-name></person-group> (<year>2011</year>) <article-title>The structure of the eukaryotic ribosome at 3.0 a resolution</article-title>. <source>Science</source>, <volume>334</volume>, <fpage>1524</fpage>&#x2013;<lpage>1529</lpage>.<pub-id pub-id-type="pmid">22096102</pub-id></mixed-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Melnikov</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Ben-Shem</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Garreau de Loubresse</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Jenner</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Yusupova</surname>, <given-names>G.</given-names></string-name> and <string-name><surname>Yusupov</surname>, <given-names>M.</given-names></string-name></person-group> (<year>2012</year>) <article-title>One core, two shells: bacterial and eukaryotic ribosomes</article-title>. <source>Nat. Struct. Mol. Biol.</source>, <volume>19</volume>, <fpage>560</fpage>&#x2013;<lpage>567</lpage>.<pub-id pub-id-type="pmid">22664983</pub-id></mixed-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Khatter</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Myasnikov</surname>, <given-names>A.G.</given-names></string-name>, <string-name><surname>Natchiar</surname>, <given-names>S.K.</given-names></string-name> and <string-name><surname>Klaholz</surname>, <given-names>B.P.</given-names></string-name></person-group> (<year>2015</year>) <article-title>Structure of the human 80S ribosome</article-title>. <source>Nature</source>, <volume>520</volume>, <fpage>640</fpage>&#x2013;<lpage>645</lpage>.<pub-id pub-id-type="pmid">25901680</pub-id></mixed-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Collins</surname>, <given-names>J.C.</given-names></string-name>, <string-name><surname>Ghalei</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Doherty</surname>, <given-names>J.R.</given-names></string-name>, <string-name><surname>Huang</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Culver</surname>, <given-names>R.N.</given-names></string-name> and <string-name><surname>Karbstein</surname>, <given-names>K.</given-names></string-name></person-group> (<year>2018</year>) <article-title>Ribosome biogenesis factor Ltv1 chaperones the assembly of the small subunit head</article-title>. <source>J. Cell Biol.</source>, <volume>217</volume>, <fpage>4141</fpage>&#x2013;<lpage>4154</lpage>.<pub-id pub-id-type="pmid">30348748</pub-id></mixed-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kim</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>H.D.</given-names></string-name>, <string-name><surname>Jung</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>J.</given-names></string-name> and <string-name><surname>Chung</surname>, <given-names>J.</given-names></string-name></person-group> (<year>2015</year>) <article-title>Drosophila low temperature viability protein 1 (LTV1) is required for ribosome biogenesis and cell growth downstream of drosophila Myc (dMyc)</article-title>. <source>J. Biol. Chem.</source>, <volume>290</volume>, <fpage>13591</fpage>&#x2013;<lpage>13604</lpage>.<pub-id pub-id-type="pmid">25858587</pub-id></mixed-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Seiser</surname>, <given-names>R.M.</given-names></string-name>, <string-name><surname>Sundberg</surname>, <given-names>A.E.</given-names></string-name>, <string-name><surname>Wollam</surname>, <given-names>B.J.</given-names></string-name>, <string-name><surname>Zobel-Thropp</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Baldwin</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Spector</surname>, <given-names>M.D.</given-names></string-name> and <string-name><surname>Lycan</surname>, <given-names>D.E.</given-names></string-name></person-group> (<year>2006</year>) <article-title>Ltv1 is required for efficient nuclear export of the ribosomal small subunit in Saccharomyces cerevisiae</article-title>. <source>Genetics</source>, <volume>174</volume>, <fpage>679</fpage>&#x2013;<lpage>691</lpage>.<pub-id pub-id-type="pmid">16888326</pub-id></mixed-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Merwin</surname>, <given-names>J.R.</given-names></string-name>, <string-name><surname>Bogar</surname>, <given-names>L.B.</given-names></string-name>, <string-name><surname>Poggi</surname>, <given-names>S.B.</given-names></string-name>, <string-name><surname>Fitch</surname>, <given-names>R.M.</given-names></string-name>, <string-name><surname>Johnson</surname>, <given-names>A.W.</given-names></string-name> and <string-name><surname>Lycan</surname>, <given-names>D.E.</given-names></string-name></person-group> (<year>2014</year>) <article-title>Genetic analysis of the ribosome biogenesis factor Ltv1 of Saccharomyces cerevisiae</article-title>. <source>Genetics</source>, <volume>198</volume>, <fpage>1071</fpage>&#x2013;<lpage>1085</lpage>.<pub-id pub-id-type="pmid">25213169</pub-id></mixed-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ghalei</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Schaub</surname>, <given-names>F.X.</given-names></string-name>, <string-name><surname>Doherty</surname>, <given-names>J.R.</given-names></string-name>, <string-name><surname>Noguchi</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Roush</surname>, <given-names>W.R.</given-names></string-name>, <string-name><surname>Cleveland</surname>, <given-names>J.L.</given-names></string-name>, <string-name><surname>Stroupe</surname>, <given-names>M.E.</given-names></string-name> and <string-name><surname>Karbstein</surname>, <given-names>K.</given-names></string-name></person-group> (<year>2015</year>) <article-title>Hrr25/CK1delta-directed release of Ltv1 from pre-40S ribosomes is necessary for ribosome assembly and cell growth</article-title>. <source>J. Cell Biol.</source>, <volume>208</volume>, <fpage>745</fpage>&#x2013;<lpage>759</lpage>.<pub-id pub-id-type="pmid">25778921</pub-id></mixed-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Fassio</surname>, <given-names>C.A.</given-names></string-name>, <string-name><surname>Schofield</surname>, <given-names>B.J.</given-names></string-name>, <string-name><surname>Seiser</surname>, <given-names>R.M.</given-names></string-name>, <string-name><surname>Johnson</surname>, <given-names>A.W.</given-names></string-name> and <string-name><surname>Lycan</surname>, <given-names>D.E.</given-names></string-name></person-group> (<year>2010</year>) <article-title>Dominant mutations in the late 40S biogenesis factor Ltv1 affect cytoplasmic maturation of the small ribosomal subunit in Saccharomyces cerevisiae</article-title>. <source>Genetics</source>, <volume>185</volume>, <fpage>199</fpage>&#x2013;<lpage>209</lpage>.<pub-id pub-id-type="pmid">20215468</pub-id></mixed-citation>
      </ref>
      <ref id="ref11">
        <label>11</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Bult</surname>, <given-names>C.J.</given-names></string-name>, <string-name><surname>Blake</surname>, <given-names>J.A.</given-names></string-name>, <string-name><surname>Smith</surname>, <given-names>C.L.</given-names></string-name>, <string-name><surname>Kadin</surname>, <given-names>J.A.</given-names></string-name>, <string-name><surname>Richardson</surname>, <given-names>J.E.</given-names></string-name>, <string-name><surname>Database</surname>, <given-names>M.G.</given-names></string-name> and G.</person-group> (<year>2019</year>) <article-title>Mouse genome database (MGD) 2019</article-title>. <source>Nucleic Acids Res.</source>, <volume>47</volume>, <fpage>D801</fpage>&#x2013;<lpage>D806</lpage>.<pub-id pub-id-type="pmid">30407599</pub-id></mixed-citation>
      </ref>
      <ref id="ref12">
        <label>12</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Martin</surname>, <given-names>A.R.</given-names></string-name>, <string-name><surname>Williams</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Foulger</surname>, <given-names>R.E.</given-names></string-name>, <string-name><surname>Leigh</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Daugherty</surname>, <given-names>L.C.</given-names></string-name>, <string-name><surname>Niblock</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Leong</surname>, <given-names>I.U.S.</given-names></string-name>, <string-name><surname>Smith</surname>, <given-names>K.R.</given-names></string-name>, <string-name><surname>Gerasimenko</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Haraldsdottir</surname>, <given-names>E.</given-names></string-name><etal>et&#xA0;al.</etal></person-group> (<year>2019</year>) <article-title>PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels</article-title>. <source>Nat. Genet.</source>, <volume>51</volume>, <fpage>1560</fpage>&#x2013;<lpage>1565</lpage>.<pub-id pub-id-type="pmid">31676867</pub-id></mixed-citation>
      </ref>
      <ref id="ref13">
        <label>13</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kohler</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Doelken</surname>, <given-names>S.C.</given-names></string-name>, <string-name><surname>Mungall</surname>, <given-names>C.J.</given-names></string-name>, <string-name><surname>Bauer</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Firth</surname>, <given-names>H.V.</given-names></string-name>, <string-name><surname>Bailleul-Forestier</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Black</surname>, <given-names>G.C.</given-names></string-name>, <string-name><surname>Brown</surname>, <given-names>D.L.</given-names></string-name>, <string-name><surname>Brudno</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Campbell</surname>, <given-names>J.</given-names></string-name><etal>et&#xA0;al.</etal></person-group> (<year>2014</year>) <article-title>The human phenotype ontology project: linking molecular biology and disease through phenotype data</article-title>. <source>Nucleic Acids Res.</source>, <volume>42</volume>, <fpage>D966</fpage>&#x2013;<lpage>D974</lpage>.<pub-id pub-id-type="pmid">24217912</pub-id></mixed-citation>
      </ref>
      <ref id="ref14">
        <label>14</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Karczewski</surname>, <given-names>K.J.</given-names></string-name>, <string-name><surname>Francioli</surname>, <given-names>L.C.</given-names></string-name>, <string-name><surname>Tiao</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Cummings</surname>, <given-names>B.B.</given-names></string-name>, <string-name><surname>Alfoldi</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Collins</surname>, <given-names>R.L.</given-names></string-name>, <string-name><surname>Laricchia</surname>, <given-names>K.M.</given-names></string-name>, <string-name><surname>Ganna</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Birnbaum</surname>, <given-names>D.P.</given-names></string-name><etal>et&#xA0;al.</etal></person-group> (<year>2020</year>) <article-title>The mutational constraint spectrum quantified from variation in 141,456 humans</article-title>. <source>Nature</source>, <volume>581</volume>, <fpage>434</fpage>&#x2013;<lpage>443</lpage>.<pub-id pub-id-type="pmid">32461654</pub-id></mixed-citation>
      </ref>
      <ref id="ref15">
        <label>15</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ng</surname>, <given-names>P.C.</given-names></string-name> and <string-name><surname>Henikoff</surname>, <given-names>S.</given-names></string-name></person-group> (<year>2003</year>) <article-title>SIFT: predicting amino acid changes that affect protein function</article-title>. <source>Nucleic Acids Res.</source>, <volume>31</volume>, <fpage>3812</fpage>&#x2013;<lpage>3814</lpage>.<pub-id pub-id-type="pmid">12824425</pub-id></mixed-citation>
      </ref>
      <ref id="ref16">
        <label>16</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Adzhubei</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Jordan</surname>, <given-names>D.M.</given-names></string-name> and <string-name><surname>Sunyaev</surname>, <given-names>S.R.</given-names></string-name></person-group> (<year>2013</year>) <article-title>Predicting functional effect of human missense mutations using PolyPhen-2</article-title>. <source>Curr. Protoc. Hum. Genet.</source><comment><bold>Chapter 7</bold>, Unit7</comment>, <fpage>20</fpage>.<pub-id pub-id-type="pmid">23315928</pub-id></mixed-citation>
      </ref>
      <ref id="ref17">
        <label>17</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Jaganathan</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Kyriazopoulou Panagiotopoulou</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>McRae</surname>, <given-names>J.F.</given-names></string-name>, <string-name><surname>Darbandi</surname>, <given-names>S.F.</given-names></string-name>, <string-name><surname>Knowles</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>Y.I.</given-names></string-name>, <string-name><surname>Kosmicki</surname>, <given-names>J.A.</given-names></string-name>, <string-name><surname>Arbelaez</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Cui</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Schwartz</surname>, <given-names>G.B.</given-names></string-name><etal>et&#xA0;al.</etal></person-group> (<year>2019</year>) <article-title>Predicting splicing from primary sequence with deep learning</article-title>. <source>Cell</source>, <volume>176</volume>, <fpage>535</fpage>&#x2013;<lpage>548 e524</lpage>.<pub-id pub-id-type="pmid">30661751</pub-id></mixed-citation>
      </ref>
      <ref id="ref18">
        <label>18</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Yeo</surname>, <given-names>G.</given-names></string-name> and <string-name><surname>Burge</surname>, <given-names>C.B.</given-names></string-name></person-group> (<year>2004</year>) <article-title>Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals</article-title>. <source>J. Comput. Biol.</source>, <volume>11</volume>, <fpage>377</fpage>&#x2013;<lpage>394</lpage>.<pub-id pub-id-type="pmid">15285897</pub-id></mixed-citation>
      </ref>
      <ref id="ref19">
        <label>19</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Quinodoz</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Peter</surname>, <given-names>V.G.</given-names></string-name>, <string-name><surname>Bedoni</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Royer Bertrand</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Cisarova</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Salmaninejad</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Sepahi</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Rodrigues</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Piran</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Mojarrad</surname>, <given-names>M.</given-names></string-name><etal>et&#xA0;al.</etal></person-group> (<year>2021</year>) <article-title>AutoMap is a high performance homozygosity mapping tool using next-generation sequencing data</article-title>. <source>Nat. Commun.</source>, <volume>12</volume>, <fpage>518</fpage>.<pub-id pub-id-type="pmid">33483490</pub-id></mixed-citation>
      </ref>
      <ref id="ref20">
        <label>20</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hentze</surname>, <given-names>M.W.</given-names></string-name> and <string-name><surname>Kulozik</surname>, <given-names>A.E.</given-names></string-name></person-group> (<year>1999</year>) <article-title>A perfect message: RNA surveillance and nonsense-mediated decay</article-title>. <source>Cell</source>, <volume>96</volume>, <fpage>307</fpage>&#x2013;<lpage>310</lpage>.<pub-id pub-id-type="pmid">10025395</pub-id></mixed-citation>
      </ref>
      <ref id="ref21">
        <label>21</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wang</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Yang</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Sun</surname>, <given-names>M.</given-names></string-name> and <string-name><surname>Li</surname>, <given-names>M.</given-names></string-name></person-group> (<year>2021</year>) <article-title>Identification of a novel mutation in the KITLG gene in a Chinese family with familial progressive hyper- and hypopigmentation</article-title>. <source>BMC Med. Genet.</source>, <volume>14</volume>, <fpage>12</fpage>.</mixed-citation>
      </ref>
      <ref id="ref22">
        <label>22</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Mitterer</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Murat</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Rety</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Blaud</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Delbos</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Stanborough</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Bergler</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Leulliot</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Kressler</surname>, <given-names>D.</given-names></string-name> and <string-name><surname>Pertschy</surname>, <given-names>B.</given-names></string-name></person-group> (<year>2016</year>) <article-title>Sequential domain assembly of ribosomal protein S3 drives 40S subunit maturation</article-title>. <source>Nat. Commun.</source>, <volume>7</volume>, <fpage>10336</fpage>.<pub-id pub-id-type="pmid">26831757</pub-id></mixed-citation>
      </ref>
      <ref id="ref23">
        <label>23</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ameismeier</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Cheng</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Berninghausen</surname>, <given-names>O.</given-names></string-name> and <string-name><surname>Beckmann</surname>, <given-names>R.</given-names></string-name></person-group> (<year>2018</year>) <article-title>Visualizing late states of human 40S ribosomal subunit maturation</article-title>. <source>Nature</source>, <volume>558</volume>, <fpage>249</fpage>&#x2013;<lpage>253</lpage>.<pub-id pub-id-type="pmid">29875412</pub-id></mixed-citation>
      </ref>
      <ref id="ref24">
        <label>24</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Mitterer</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Shayan</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Ferreira-Cerca</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Murat</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Enne</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Rinaldi</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Weigl</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Omanic</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Gleizes</surname>, <given-names>P.E.</given-names></string-name>, <string-name><surname>Kressler</surname>, <given-names>D.</given-names></string-name><etal>et&#xA0;al.</etal></person-group> (<year>2019</year>) <article-title>Conformational proofreading of distant 40S ribosomal subunit maturation events by a long-range communication mechanism</article-title>. <source>Nat. Commun.</source>, <volume>10</volume>, <fpage>2754</fpage>.<pub-id pub-id-type="pmid">31227701</pub-id></mixed-citation>
      </ref>
      <ref id="ref25">
        <label>25</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Panse</surname>, <given-names>V.G.</given-names></string-name> and <string-name><surname>Johnson</surname>, <given-names>A.W.</given-names></string-name></person-group> (<year>2010</year>) <article-title>Maturation of eukaryotic ribosomes: acquisition of functionality</article-title>. <source>Trends Biochem. Sci.</source>, <volume>35</volume>, <fpage>260</fpage>&#x2013;<lpage>266</lpage>.<pub-id pub-id-type="pmid">20137954</pub-id></mixed-citation>
      </ref>
      <ref id="ref26">
        <label>26</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Schafer</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Maco</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Petfalski</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Tollervey</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Bottcher</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Aebi</surname>, <given-names>U.</given-names></string-name> and <string-name><surname>Hurt</surname>, <given-names>E.</given-names></string-name></person-group> (<year>2006</year>) <article-title>Hrr25-dependent phosphorylation state regulates organization of the pre-40S subunit</article-title>. <source>Nature</source>, <volume>441</volume>, <fpage>651</fpage>&#x2013;<lpage>655</lpage>.<pub-id pub-id-type="pmid">16738661</pub-id></mixed-citation>
      </ref>
      <ref id="ref27">
        <label>27</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Consortium</surname>, <given-names>G.T.</given-names></string-name>
</person-group> (<year>2013</year>) <article-title>The genotype-tissue expression (GTEx) project</article-title>. <source>Nat. Genet.</source>, <volume>45</volume>, <fpage>580</fpage>&#x2013;<lpage>585</lpage>.<pub-id pub-id-type="pmid">23715323</pub-id></mixed-citation>
      </ref>
      <ref id="ref28">
        <label>28</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Knight</surname>, <given-names>S.W.</given-names></string-name>, <string-name><surname>Heiss</surname>, <given-names>N.S.</given-names></string-name>, <string-name><surname>Vulliamy</surname>, <given-names>T.J.</given-names></string-name>, <string-name><surname>Greschner</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Stavrides</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Pai</surname>, <given-names>G.S.</given-names></string-name>, <string-name><surname>Lestringant</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Varma</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Mason</surname>, <given-names>P.J.</given-names></string-name>, <string-name><surname>Dokal</surname>, <given-names>I.</given-names></string-name><etal>et&#xA0;al.</etal></person-group> (<year>1999</year>) <article-title>X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene</article-title>. <source>Am. J. Hum. Genet.</source>, <volume>65</volume>, <fpage>50</fpage>&#x2013;<lpage>58</lpage>.<pub-id pub-id-type="pmid">10364516</pub-id></mixed-citation>
      </ref>
      <ref id="ref29">
        <label>29</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Heiss</surname>, <given-names>N.S.</given-names></string-name>, <string-name><surname>Knight</surname>, <given-names>S.W.</given-names></string-name>, <string-name><surname>Vulliamy</surname>, <given-names>T.J.</given-names></string-name>, <string-name><surname>Klauck</surname>, <given-names>S.M.</given-names></string-name>, <string-name><surname>Wiemann</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Mason</surname>, <given-names>P.J.</given-names></string-name>, <string-name><surname>Poustka</surname>, <given-names>A.</given-names></string-name> and <string-name><surname>Dokal</surname>, <given-names>I.</given-names></string-name></person-group> (<year>1998</year>) <article-title>X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions</article-title>. <source>Nat. Genet.</source>, <volume>19</volume>, <fpage>32</fpage>&#x2013;<lpage>38</lpage>.<pub-id pub-id-type="pmid">9590285</pub-id></mixed-citation>
      </ref>
      <ref id="ref30">
        <label>30</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Nakhoul</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Ke</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Liao</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Zeng</surname>, <given-names>S.X.</given-names></string-name> and <string-name><surname>Lu</surname>, <given-names>H.</given-names></string-name></person-group> (<year>2014</year>) <article-title>Ribosomopathies: mechanisms of disease</article-title>. <source>Clin Med Insights Blood Disord</source>, <volume>7</volume>, <fpage>7</fpage>&#x2013;<lpage>16</lpage>.<pub-id pub-id-type="pmid">25512719</pub-id></mixed-citation>
      </ref>
      <ref id="ref31">
        <label>31</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Bellodi</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>McMahon</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Contreras</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Juliano</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Kopmar</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Nakamura</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Maltby</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Burlingame</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Savage</surname>, <given-names>S.A.</given-names></string-name>, <string-name><surname>Shimamura</surname>, <given-names>A.</given-names></string-name><etal>et&#xA0;al.</etal></person-group> (<year>2013</year>) <article-title>H/ACA small RNA dysfunctions in disease reveal key roles for noncoding RNA modifications in hematopoietic stem cell differentiation</article-title>. <source>Cell Rep.</source>, <volume>3</volume>, <fpage>1493</fpage>&#x2013;<lpage>1502</lpage>.<pub-id pub-id-type="pmid">23707062</pub-id></mixed-citation>
      </ref>
      <ref id="ref32">
        <label>32</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>MacDonald</surname>, <given-names>C.</given-names></string-name> and <string-name><surname>Piper</surname>, <given-names>R.C.</given-names></string-name></person-group> (<year>2017</year>) <article-title>Genetic dissection of early endosomal recycling highlights a TORC1-independent role for rag GTPases</article-title>. <source>J. Cell Biol.</source>, <volume>216</volume>, <fpage>3275</fpage>&#x2013;<lpage>3290</lpage>.<pub-id pub-id-type="pmid">28768685</pub-id></mixed-citation>
      </ref>
      <ref id="ref33">
        <label>33</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Bare</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Chan</surname>, <given-names>G.K.</given-names></string-name>, <string-name><surname>Hayday</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>McGrath</surname>, <given-names>J.A.</given-names></string-name> and <string-name><surname>Parsons</surname>, <given-names>M.</given-names></string-name></person-group> (<year>2021</year>) <article-title>Slac2-b coordinates extracellular vesicle secretion to regulate keratinocyte adhesion and migration</article-title>. <source>J. Invest. Dermatol.</source>, <volume>141</volume>, <fpage>523</fpage>&#x2013;<lpage>532.e2</lpage>.<pub-id pub-id-type="pmid">32890627</pub-id></mixed-citation>
      </ref>
      <ref id="ref34">
        <label>34</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hume</surname>, <given-names>A.N.</given-names></string-name>, <string-name><surname>Collinson</surname>, <given-names>L.M.</given-names></string-name>, <string-name><surname>Rapak</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Gomes</surname>, <given-names>A.Q.</given-names></string-name>, <string-name><surname>Hopkins</surname>, <given-names>C.R.</given-names></string-name> and <string-name><surname>Seabra</surname>, <given-names>M.C.</given-names></string-name></person-group> (<year>2001</year>) <article-title>Rab27a regulates the peripheral distribution of melanosomes in melanocytes</article-title>. <source>J. Cell Biol.</source>, <volume>152</volume>, <fpage>795</fpage>&#x2013;<lpage>808</lpage>.<pub-id pub-id-type="pmid">11266470</pub-id></mixed-citation>
      </ref>
      <ref id="ref35">
        <label>35</label>
        <mixed-citation publication-type="book">
<person-group person-group-type="author">
<string-name>
<surname>Caulfield</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Davies</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Dennys</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Elbahy</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Fowler</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Hill</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Hubbard</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Jostins</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Maltby</surname>, <given-names>N.</given-names></string-name> and <string-name><surname>Mahon-Pearson</surname>, <given-names>J.</given-names></string-name></person-group> (<year>2020</year>) <source>The National Genomic Research Library v5.1</source>. <pub-id pub-id-type="doi">10.6084/m9.figshare.4530893.v6</pub-id>.</mixed-citation>
      </ref>
      <ref id="ref36">
        <label>36</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Turnbull</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Scott</surname>, <given-names>R.H.</given-names></string-name>, <string-name><surname>Thomas</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Jones</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Murugaesu</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Pretty</surname>, <given-names>F.B.</given-names></string-name>, <string-name><surname>Halai</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Baple</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Craig</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Hamblin</surname>, <given-names>A.</given-names></string-name><etal>et&#xA0;al.</etal></person-group> (<year>2018</year>) <article-title>The 100 000 genomes project: bringing whole genome sequencing to the NHS</article-title>. <source>BMJ</source>, <volume>361</volume>, <elocation-id>k1687</elocation-id>.<pub-id pub-id-type="pmid">29691228</pub-id></mixed-citation>
      </ref>
      <ref id="ref37">
        <label>37</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Sherry</surname>, <given-names>S.T.</given-names></string-name>, <string-name><surname>Ward</surname>, <given-names>M.H.</given-names></string-name>, <string-name><surname>Kholodov</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Baker</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Phan</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Smigielski</surname>, <given-names>E.M.</given-names></string-name> and <string-name><surname>Sirotkin</surname>, <given-names>K.</given-names></string-name></person-group> (<year>2001</year>) <article-title>dbSNP: the NCBI database of genetic variation</article-title>. <source>Nucleic Acids Res.</source>, <volume>29</volume>, <fpage>308</fpage>&#x2013;<lpage>311</lpage>.<pub-id pub-id-type="pmid">11125122</pub-id></mixed-citation>
      </ref>
      <ref id="ref38">
        <label>38</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Peter</surname>, <given-names>V.G.</given-names></string-name>, <string-name><surname>Nikopoulos</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Quinodoz</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Granse</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Farinelli</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Superti-Furga</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Andreasson</surname>, <given-names>S.</given-names></string-name> and <string-name><surname>Rivolta</surname>, <given-names>C.</given-names></string-name></person-group> (<year>2019</year>) <article-title>A novel missense variant in IDH3A causes autosomal recessive retinitis pigmentosa</article-title>. <source>Ophthalmic Genet.</source>, <volume>40</volume>, <fpage>177</fpage>&#x2013;<lpage>181</lpage>.<pub-id pub-id-type="pmid">31012789</pub-id></mixed-citation>
      </ref>
      <ref id="ref39">
        <label>39</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Peter</surname>, <given-names>V.G.</given-names></string-name>, <string-name><surname>Quinodoz</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Pinto-Basto</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Sousa</surname>, <given-names>S.B.</given-names></string-name>, <string-name><surname>Di Gioia</surname>, <given-names>S.A.</given-names></string-name>, <string-name><surname>Soares</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Ferraz Leal</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Silva</surname>, <given-names>E.D.</given-names></string-name>, <string-name><surname>Pescini Gobert</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Miyake</surname>, <given-names>N.</given-names></string-name><etal>et&#xA0;al.</etal></person-group> (<year>2019</year>) <article-title>The Liberfarb syndrome, a multisystem disorder affecting eye, ear, bone, and brain development, is caused by a founder pathogenic variant in thePISD gene</article-title>. <source>Genet. Med.</source>, <volume>21</volume>, <fpage>2734</fpage>&#x2013;<lpage>2743</lpage>.<pub-id pub-id-type="pmid">31263216</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>